A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation

Bone Marrow Transplantation

Volumn 19, Issue 6, 1997, Pages 615-619

  Bertolini, F ^a   Thomas, T ^b   Battaglia, M ^a   Gibelli, N ^a   Pedrazzoli, P ^a   Della Cuna, G Robustelli ^a  

^a IRCCS   (Italy)

^b StemCell Technologies Inc   (Canada)

Author keywords

Processing; Progenitor cell; Purging; Stem cell; Transplantation

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN;

ALLOGENIC BONE MARROW TRANSPLANTATION; APHERESIS; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; B LYMPHOCYTE; BONE MARROW PURGING; BREAST CANCER; CELL SELECTION; CELL SUSPENSION; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; METHODOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

EID: 0030940994     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700709     Document Type: Article

References (19)

1. Aversa F, Tabilio A, Terenza A et al. Successful engraftment of T cell-depleted haploidentical 'three loci' incompatible transplants in leukemia patients by addition of recombinant human G-CSF-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948-3955.
2. Gratama JW. Epstein-Barr virus infections in bone marrow transplant recipients. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell: Boston, 1994, pp 429-442.
3. Shpall EJ, Jones RB. Mobilization and collection of peripheral blood progenitor cells for support of high-dose cancer therapy. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackweli: Boston, 1994. pp 913-918.
4. Gee AP. Graft manipulation - a house of cards? (editorial) J Hematother 1994; 3: 1-2.
5. Champlin R. Purging: the separation of normal from malignant cells for autologous transplantation (review). Transfusion 1996; 36: 910-918.
6. Cordell JL, Falini B, Erber WN et al. Immunoenzymatic labeling of monoclonal antibodies using immuno complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-229.
7. Pettengell R, Luft T, Henschler R et al. Direct comparisons by limiting dilution analysis of LTC-IC in human bone marrow, umbilical cord blood and blood stem cells. Blood 1994; 84: 3653-3659.
8. + cell selection enrich malignant stem cells in B cell (and other) malignancies? J Hematother 1996; 5: 97-98 (letter).
9. Hows JM, Bradley BA, Marsh JCW et al. Growth of human umbilical-cord blood in long-term haematopoietic cultures. Lancet 1992; 340: 73-76.
10. Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 1994; 8: 1095-1104.
11. Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells. Immunol Today 1995; 16: 437-440.
12. Reynolds CP, Seeger RC, Vo DD et al. Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Res 1986; 46 5882-5886.
13. O'Briant KC, Shpall EJ, Houston LL et al. Elimination of clonogenic breast cancer cells from human bone marrow: a comparison of immunotoxin treatment with chemo-immunose-paration using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres. Cancer 1991; 68: 1272-1278.
14. + cells. Blood 1995; 86: 2500-2508.
15. + cells to remove circulating tumor cells. Blood 1996; 87: 1625-1634.
16. + progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients. Blood 1995; 86: 4691-4698.
17. Bardy P, Watson P, Kaur P et al. Characterization of monoclonal antibodies to epithelial antigens expressed on breast cancer cells and absent on hematopoietic cells. Blood 1995; 86 (Suppl. 1): 233a (Abstr. 920).
18. Kohler G, Brugger W, Schaefer HE et al. Expression of CD34 stem cell antigen on tumor cells. Blood 1994; 84 (Suppl. 1): 497a (Abstr. 1975).
19. Wessman M, Schnell J, VanDenBerg D et al. Fluoresent detection of metastatic breast cancer cells in bone marrow and mobilized peripheral blood by immune-fluorescence and by high-speed flow cytometry. Blood 1995; 86 (Suppl. 1): 233a (Abstr. 919).